Artigo
Revisado por pares
Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)
2008; Elsevier BV; Volume: 155; Issue: 4 Linguagem: Inglês
10.1016/j.ahj.2007.11.029
ISSN1097-6744
AutoresRobert Wilcox, Stuart Kupfer, Erland Erdmann,
Tópico(s)Antiplatelet Therapy and Cardiovascular Diseases
Referência(s)